Some GLP-1 agonists (particularly semaglutide) carry warnings about diabetic retinopathy complications
Teaching kitchen curricula for clinicians and individuals has emerging evidence for enhancing nutrition knowledge, culinary skills, and dietary pattern change [[254], [255], [256]]
There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond
2025 DOI: 10.1038/s44324-025-00054-5 PMID: 40094000 Read on PubMed 10 peer-reviewed references listed
Efficacy of Liraglutide for Weight Loss Among Patients with Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial
Patients should avoid choosing a medication based only on headline weight-loss percentages